Hikma Pharmaceuticals is a multinational pharmaceutical company that develops, manufactures, and markets a broad range of generic, branded, and injectable pharmaceutical products. It is a leading supplier of sterile injectable medicines in the U.S. and operates one of the largest generics businesses in the MENA region.
Company Info
Upcoming Milestones & Key Dates
Q1 2026 Earnings — Injectables franchise and Ohio expansion update
First production from expanded Ohio facilities
Clinical Development Pipeline
Recent News
Hikma Pharmaceuticals announced a $267 million investment across its Ohio manufacturing facilities, expected to create 350 new jobs and expand sterile injectable and generic drug production capacity in the U.S. market.
Hikma outlines plan to invest $267M in Ohio plants, creating 350 jobs.
Leadership Team
Careers & Job Openings